This inventor holds 4 USPTO granted patents. Top assignees: Ardea Biosciences, Inc, Merck + Co., Inc.. Active years: 2006-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006-2016
Title: The Innovations of Jean Michel Vernier
Introduction
Jean Michel Vernier is a notable inventor based in San Diego, California. He has made significant contributions to the field of pharmaceuticals, holding a total of four patents. His work focuses on the preparation of complex chemical compounds that have potential applications in medicine.
Latest Patents
Vernier's latest patents include the preparation of (R)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and (S)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide. These inventions relate to the synthesis of specific sulfonamide compounds that may have therapeutic benefits.
Career Highlights
Throughout his career, Vernier has worked with prominent companies in the pharmaceutical industry, including Ardea Biosciences, Inc. and Merck & Company, Inc. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Vernier has collaborated with notable professionals in his field, including Peter Charles Astles and Stephen Richard Baker. These partnerships have likely enhanced his research and development efforts.
Conclusion
Jean Michel Vernier's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to impact the industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile